VaxArray® for Coronavirus
Clinical Efficacy and Vaccine Potency Testing from a Single Platform
Analytics for coronavirus vaccines compatible with next generation vaccine platform technology
Accelerate coronavirus vaccine development by utilizing VaxArray’s rapid analytical platform to empower vaccine clinical efficacy studies, investigate population-level seroprevalence, or provide insight into vaccine manufacturing steps. VaxArray is a powerful platform technology, rapidly deployed to address the need of manufacturers developing life saving coronavirus vaccines. Use the VaxArray Coronavirus Spike Protein Assay for analysis of vaccine samples, or use the VaxArray Coronavirus SeroAssay for simultaneous measurements of antibody response to SARS-CoV-2 antigens and other endemic human coronaviruses.
Kits Available
Coronavirus SeroAssay
Benefits
- Fast and easy with <30 minutes hands on time and less than 1 hour to result
- Multiplexed analysis of current and past endemic strains
- 100% Clinical Specificity and and 98.5% Clinical Sensitivity
- Compatible with recombinant, peptide, VLP and other advanced vaccine technologies
Applications
- Evaluate serological samples from preclinical and clinical studies
- Screen immunological profile of study participants against all human coronaviruses
- Quantify vaccine immunogenicity
- Confirm cross protection against 7 different coronaviruses
- Research population level seroprevalence
Coronavirus Spike Protein Assay
Benefits
- ~ 1 hour from samples to result. 30 minutes hands on time
-
Analysis of vaccine binding to ACE2 protein
- Lower limit of detection is <15 ng/mL
-
Compatible with recombinant, subunit, VLP, and other advanced vaccine technologies
Applications
- Quantify antigen directly
- Optimize manufacturing process steps
- Control vaccine quality in release testing
- Evaluate stability and ACE2 binding of vaccine
- Characterize vaccine samples
- Monitor vaccine shelf life
Relevant Resources
VaxArray Platform for Coronavirus
10 min Introduction video to VaxArray for Coronavirus
Serological Assay for Antibodies Against All Human-relevant Coronaviruses
Accelerating Development of Covid-19 Vaccines
Kentucky BioProcessing – Development of SARS-CoV-2 Vaccine Candidate
Other Services
Coronavirus Testing Services
Prefer InDevR to run your samples? Inquire about our standard testing services using this kit.
VaxArray Custom Kits
InDevR can develop a custom kit that improves your vaccine development or serological testing needs.
